Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports
Abstract SMARCA4, one of the subunits of the switch/sucrose nonfermentable (SWI/SNF) chromatin-remodeling complex, plays a pivotal role in transcriptional regulation. By disrupting histone-DNA contacts, this complex modulates gene expression patterns, and accumulating evidence suggests its tumor sup...
Saved in:
| Main Authors: | Liwen Wang, Hua Ke, Chengdi Wang, Ke Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03060-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report: FAP+ fibroblasts and SPP1+ macrophages in SMARCA2-deficient while SMARCA4-preserved poorly differentiated lung adenocarcinoma: two case reports and multi-omics analysis
by: Zhaoxuan Wang, et al.
Published: (2025-05-01) -
Concurrent SMARCA4-deficient and poorly differentiated adenocarcinomas in separate lung lobes: a case report and literature review
by: Lu Wang, et al.
Published: (2025-05-01) -
Metastatic SMARCA4-deficient undifferentiated tumor in the small mesentery: case report
by: Shuai Luo, et al.
Published: (2024-12-01) -
Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report
by: Ming-xing Wang, et al.
Published: (2025-01-01) -
Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: a case report and molecular features
by: Ting Duan, et al.
Published: (2024-12-01)